1 |
Park, M. Y., Ahn, K. Y., Jung, D. S. Botulinum toxin type A treatment for contouring of the lower face. 2003;29:477-483.
DOI
ScienceOn
|
2 |
Choe, S. W., Cho, W. I., Lee, C. K., et al. Effects of botulinum toxin type A on contouring of the lower face. 2005;31:502-507;discussion507.
DOI
|
3 |
Kim, N. H., Chung, J. H., Park, R. H., et al. The use of botulinum toxin type A in aesthetic mandibular contouring. PlastReconstrSurg 2005;115:919-930.
DOI
ScienceOn
|
4 |
Blitzer, A., Brin, M. F., Keen, M. S., et al. Botulinum toxin for the treatment of hyperfunctional lines of the face. ArchOtolaryngolHeadNeckSurg 1993;119:1018-1022.
DOI
ScienceOn
|
5 |
Carruthers, J. A., Lowe, N. J., Menter, M. A., et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. JAmAcadDermatol 2002;46:840-849.
DOI
ScienceOn
|
6 |
Blitzer, A., Binder, W. J., Aviv, J. E., et al. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients. ArchOtolaryngolHeadNeckSurg 1997;123:389-392.
DOI
|
7 |
Borodic, G. E., Ferrante, R. Effects of repeated botulinum toxin injections on orbicularis oculi muscle. JClinNeuroophthalmol 1992;12:121-127.
DOI
|
8 |
Rzany B,Dill-Muller D,Grablowitz D,Heckmann M,Caird D;German-Austrian Retrospective Study Group. Repeated botulinumtoxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients. 2007;33:S18-25.
DOI
ScienceOn
|
9 |
Oshima, M., Middlebrook, J. L., Atassi, M. Z. Antibodies and T cells against synthetic peptides of the C-terminal domain (Hc) of botulinum neurotoxin type A and their cross-reaction with Hc. ImmunolLett 1998;60:7-12.
DOI
ScienceOn
|
10 |
Clark, G. T. The management of oromandibular motor disorders and facial spasms with injections of botulinum toxin. PhysMedRehabilClinNAm 2003;14:727-748.
DOI
ScienceOn
|
11 |
Moore, A. P., Wood, G. D. The medical management of masseteric hypertrophy with botulinum toxin type A. BrJOralMaxillofacSurg 1994;32:26-28.
DOI
ScienceOn
|
12 |
To, E. W., Ahuja, A. T., Ho, W. S., et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. BrJPlastSurg 2001;54:197-200.
|
13 |
Jankovic, J., Brin, M. F. Therapeutic uses of botulinum toxin. NEnglJMed 1991;324:1186-1194.
DOI
ScienceOn
|
14 |
Yu, C. C., Chen, P. K., Chen, Y. R. Botulinum toxin a for lower facial contouring: a prospective study. AestheticPlastSurg 2007;31:445-451;discussion452.
DOI
ScienceOn
|
15 |
Alam, M., Dover, J. S., Klein, A. W., et al. Botulinum a exotoxin for hyperfunctional facial lines: where not to inject. ArchDermatol 2002;138:1180-1185.
DOI
ScienceOn
|
16 |
Ahn, K. Y., Kim, S. T. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy. PlastReconstrSurg 2007;120:1662-1666.
DOI
ScienceOn
|
17 |
Simpson, L. L. Botulinum toxin: a deadly poison sheds its negative image. AnnInternMed 1996;125:616-617.
DOI
ScienceOn
|
18 |
Carruthers, J. D., Carruthers, J. A. Treatment of glabellar frown lines with C. botulinum-A exotoxin. JDermatolSurgOncol 1992;18:17-21.
DOI
ScienceOn
|
19 |
Borodic, G. E., Ferrante, R., Pearce, L. B., et al. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. MovDisord 9:31-39,1994.
DOI
ScienceOn
|
20 |
Kim, H. J., Yum, K. W., Lee, S. S., et al. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement. 2003;29:484-489.
DOI
ScienceOn
|
21 |
Kim, J. H., Shin, J. H., Kim, S. T., et al. Effects of two different units of botulinum toxin type a evaluated by computed tomography and electromyographic measurementsted tuman masseter muscle. PlastReconstrSurg 2007;119:711-717.
DOI
ScienceOn
|